日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lost in the Edit: Reclaiming the Clinical Narrative in the Age of Synthetic Records

迷失在编辑中:在合成记录时代重塑临床叙事

Lakhan, Shaheen E

Brainspan: A Framework for Defining, Measuring, and Preserving Cognitive Longevity

脑力寿命:定义、测量和保持认知寿命的框架

Lakhan, Shaheen E

The Clinician as DIRECTOR: Operationalizing Cinematic Storytelling for Clinical Documentation in the Age of Artificial Intelligence

临床医生作为导演:在人工智能时代将电影化叙事手法应用于临床文档

Lakhan, Shaheen E

The Brain Is the Rate-Limiting Organ of Longevity: A Brain-First Systems Framework for Aging

大脑是限制寿命的器官:一种以大脑为先导的衰老系统框架

Lakhan, Shaheen E

Software-Enhanced Drugs™: The third platform reshaping drug development

软件增强型药物™:重塑药物研发的第三个平台

Lakhan, Shaheen E; Wicks, Paul

Clinical outcome of guided endodontics versus freehand drilling: A controlled clinical trial, single arm with external control group

引导式根管治疗与徒手钻孔的临床疗效比较:一项单组外部对照组对照临床试验

Torres, A; Dierickx, M; Lerut, K; Bleyen, S; Shaheen, E; Coucke, W; Pedano, M S; Lambrechts, P; Jacobs, R

Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies

在患有精神分裂症阴性症状的患者中建立和维护数字治疗联盟:两项探索性单臂研究

Snipes, Cassandra; Dorner-Ciossek, Cornelia; Hare, Brendan D; Besedina, Olya; Campellone, Tim; Petrova, Mariya; Lakhan, Shaheen E; Pratap, Abhishek

Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study

数字疗法治疗精神分裂症体验性阴性症状的可行性:一项探索性研究的结果

Goenjian, Haig; Pratap, Abhishek; Snipes, Cassandra; Hare, Brendan D; Kantrowitz, Joshua T; Dennis, Tshekedi; McNeel, Wakelin; Ung, Eehwa; Besedina, Olya; Gupta, Alankar; Campellone, Tim; Petrova, Mariya; Perocco, Sergio; Vaidyanathan, Uma; Lakhan, Shaheen E; Dorner-Ciossek, Cornelia

Validation of mixed reality in planning orbital reconstruction with patient-specific implants

混合现实技术在利用患者特异性植入物进行眼眶重建规划中的验证

Dubron, K; Shaheen, E; Jacobs, R; Politis, C; Willaert, R

Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial

数字疗法(CT-155/BI 3972080)治疗精神分裂症患者阴性症状的有效性、参与度和安全性:3期CONVOKE随机对照试验方案

Lakhan, Shaheen E; Dorner-Ciossek, Cornelia; Besedina, Olya; Dickerson, Faith; Hastedt, Claudia; Isla, Ridwana; Kahn, René S; Lindenmayer, Jean-Pierre; Mehta, Ruchi; Snipes, Cassandra; Speier, Austin; Tang, Wenbo; Willis, Bailey; Fernandez, Jamie Winderbaum; von der Goltz, Christoph; Pratap, Abhishek